Article Information
- Received July 15, 2013
- Revision received March 4, 2014
- Accepted March 31, 2014
- First published April 30, 2014.
- Version of record published April 30, 2014.
Author Information
Author contributions
S.Sc. and E.O. contributed unpublished reagents/analytic tools; H.H.S. and M.F. designed research; T.R.M., T.S., S.Su., and F.K. performed research; T.R.M., T.S., S.Su., F.K., H.H.S., and M.F. analyzed data; T.R.M. and M.F. wrote the paper.
↵*T.R.M. and T.S. contributed equally to this work.
Disclosures
- Received July 15, 2013.
- Revision received March 4, 2014.
- Accepted March 31, 2014.
This work was supported by Austrian Science Fund (FWF)-sponsored Collaborative Research Program SFB-35 and the FWF-funded doctoral programs CCHD (W1205-B09) and MolTag (W1232-B11). T.R.M is a recipient of a Health Research Board/Marie-Curie postdoctoral mobility research fellowship. We thank Cornelius Gross (European Molecular Biology Laboratory, Monterotondo, Italy) for providing SERT–CRE mice, Yelena Kanter, David Sulzer, and Stephan Rayport (Department for Neurology and Psychiatry, Columbia University, New York, NY) for their assistance in and advice on establishing ex vivo neuronal cultures, and Joachim Geyer for the plasmid encoding GFP–VMAT2. We are also grateful to Marion Gröger and Sabine Rauscher of the Core Facility Imaging Unit (Medical University of Vienna, Vienna, Austria) for their assistance in confocal imaging.
- Correspondence should be addressed to Michael Freissmuth, Institute of Pharmacology, Center of Physiology and Pharmacology, Medical University of Vienna, Waehringer Strasse 13a, A-1090 Vienna, Austria. michael.freissmuth{at}meduniwien.ac.at
Online Impact